Acorda Therapeutics, Inc. (ACOR) Financials

Stock symbol ACOR is outdated, potentially delisted? Maybe it is available on other exchange?

ACOR Assets vs Liabilities

Date	Assets	Liabilities
Sept. 30, 2023	366.3 million	307.4 million
June 30, 2023	364.7 million	296.8 million
March 31, 2023	374.9 million	297.9 million
Dec. 31, 2022	395.6 million	302.0 million

ACOR Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.

Date	Free Cash Flow	Stock based compensation
Sept. 30, 2023	7.4 million	141000
June 30, 2023	-11.6 million	128000
March 31, 2023	-7.0 million	71000
Dec. 31, 2022	9.1 million	173000

ACOR Net Income

No data available :(

ACOR Cash and Debt

Graph available only for paid members. Upgrade to see it.

Date	Cash	Debt	Capital Lease
Sept. 30, 2023	32.5 million	-	5.0 million
June 30, 2023	25.3 million	-	5.3 million
March 31, 2023	30.3 million	-	5.6 million
Dec. 31, 2022	37.5 million	-	5.9 million

ACOR Shares Outstanding

Graph available only for paid members. Upgrade to see it.

Date	Shares Outstanding
Sept. 30, 2023	1.2 million
June 30, 2023	1.2 million
March 31, 2023	1.2 million
Dec. 31, 2022	2.2 million

ACOR Expenses

Graph available only for paid members. Upgrade to see it.

Date	Capex	R&D	G&A	S&M
Sept. 30, 2023	220000	1.2 million	23.2 million	-
June 30, 2023	-	1.6 million	21.8 million	-
March 31, 2023	-	1.4 million	22.5 million	-
Dec. 31, 2022	14000	1.2 million	26.3 million	-

ACOR Cost of Revenue

Graph available only for paid members. Upgrade to see it.

Date	Revenue	Cost of Revenue
Sept. 30, 2023	27.7 million	3.4 million
June 30, 2023	29.7 million	3.1 million
March 31, 2023	22.3 million	3.2 million
Dec. 31, 2022	31.5 million	4.6 million

ACOR

Price: $0.66

52 week price:

0.25

24.20

Earnings Per Share: -203.57 USD

P/E Ratio: 5.98

Exchange: NMS

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Country: United States

Volume: 250200

Ebitda: -218.1 million

Market Capitalization: 821028

Links:

ACOR on Yahoo Finance